Blackbaud - BLKB Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blackbaud in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" BLKB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BLKB, but not buy additional shares or sell existing shares.
View BLKB analyst ratings or view top-rated stocks.

1 analysts have issued twelve-month price objectives for Blackbaud's stock. Their BLKB share price forecasts range from $70.00 to $70.00. On average, they expect the company's stock price to reach $70.00 in the next year. This suggests a possible upside of 24.0% from the stock's current price.
View analysts price targets for BLKB or view top-rated stocks among Wall Street analysts.

Blackbaud's stock was trading at $78.98 at the beginning of 2022. Since then, BLKB shares have decreased by 28.6% and is now trading at $56.43.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our BLKB earnings forecast.

Blackbaud, Inc. (NASDAQ:BLKB) posted its quarterly earnings results on Tuesday, November, 1st. The technology company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.15 by $0.11. The technology company had revenue of $261.30 million for the quarter, compared to the consensus estimate of $261.38 million. Blackbaud had a negative net margin of 3.03% and a positive trailing twelve-month return on equity of 6.95%.

Blackbaud updated its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided EPS guidance of $2.43-$2.63 for the period, compared to the consensus EPS estimate of $2.53. The company issued revenue guidance of $1.05 billion-$1.07 billion, compared to the consensus revenue estimate of $1.06 billion.

599 employees have rated Blackbaud Chief Executive Officer Michael Gianoni on Glassdoor.com. Michael Gianoni has an approval rating of 82% among the company's employees. 74.0% of employees surveyed would recommend working at Blackbaud to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Blackbaud investors own include CVS Health (CVS), Intel (INTC), Suncor Energy (SU), Broadcom (AVGO), Bank of America (BAC), Baidu (BIDU), Fortinet (FTNT), IPG Photonics (IPGP), McDonald's (MCD) and Marathon Petroleum (MPC).

Blackbaud trades on the NASDAQ under the ticker symbol "BLKB."

Blackbaud's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (9.84%), Vanguard Group Inc. (9.61%), State Street Corp (2.87%), Dimensional Fund Advisors LP (1.59%), Geneva Capital Management LLC (1.33%) and Palisade Capital Management LLC NJ (1.06%). Insiders that own company stock include Andrew Brannan, Andrew M Leitch, Anthony W Boor, George H Ellis, Jon W Olson, Joyce Nelson, Kevin Mcdearis, Kevin P Gregoire, Kevin W Mooney, Michael P Gianoni and Sarah E Nash.
View institutional ownership trends.

Shares of BLKB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BLKB stock can currently be purchased for approximately $56.43.

Blackbaud (NASDAQ:BLKB) has a market capitalization of $3.00 billion and generates $927.74 million in revenue each year. The technology company earns $5.70 million in net income (profit) each year or ($0.62) on an earnings per share basis.

The company employs 3,600 workers across the globe.

Blackbaud's mailing address is 65 FAIRCHILD STREET, CHARLESTON SC, 29492. The official website for the company is www.blackbaud.com. The technology company can be reached via phone at (843) 216-6200, via email at steve.hufford@blackbaud.com, or via fax at 843-216-6100.